UroGen Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
URGN Key Statistics
Stock Snapshot
With a market cap of 1.43B, UroGen Pharma(URGN) trades at $29.40. The stock has a price-to-earnings ratio of -10.67.
As of 2026-05-10, UroGen Pharma(URGN) stock has fluctuated between $26.60 and $30.45. The current price stands at $29.40, placing the stock +10.5% above today's low and -3.4% off the high.
UroGen Pharma(URGN) shares are trading with a volume of 1.68M, against a daily average of 994.25K.
In the last year, UroGen Pharma(URGN) shares hit a 52-week high of $30.45 and a 52-week low of $3.42.
In the last year, UroGen Pharma(URGN) shares hit a 52-week high of $30.45 and a 52-week low of $3.42.
URGN News
Advertisement What recent performance says about UroGen Pharma (URGN) Without a clear single event driving headlines, UroGen Pharma (URGN) has still drawn att...
Urogen Pharma ((URGN)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and power...
Reports Q1 revenue $50.96M, consensus $55.71M. “2026 is off to a strong start, with expanding usage of ZUSDURI for intravesical solution and clear acceleration...
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.